| Autor: |
Wells J; Center for Animal and Human Health in Appalachia, College of Veterinary Medicine, Lincoln Memorial University, Harrogate, Tennessee, USA., Watson K; Center for Animal and Human Health in Appalachia, College of Veterinary Medicine, Lincoln Memorial University, Harrogate, Tennessee, USA., Daniel CR; Department of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA., Brodell RT; Department of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA., Nahar VK; Associate Professor of Dermatology and Preventive Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA. |
| Abstrakt: |
Competing Interests: Robert T. Brodell has participated in multicenter clinical trials with Corevitas (formerly Corrona) Psoriasis Registry and Novartis. He has received grant from Pfizer. He is also an associate editor of the Journal of the American Academy of Dermatology, Faculty advisor for the American Medical Student Research Journal, and editor-in-chief of Practice Update: Dermatology and serves as Staff Dermatologist at the GV (Sonny) MONTGOMERY VA HOSPITAL in Jackson, MS. Daniel III C. Ralph is board of directors of Council for Nail Disorders, European Nail Society, and St. Dominic Health Services Foundation. He is also a Clinical Professor of Dermatology at the University of Alabama at Birmingham. He is also American Dermatological Association Chairman of the Endowment Committee. He serves on the editorial board of the Skin Appendages Disorders and on the advisory board of Ortho Pharmaceutical. He is also co-editor of a book Scher and Daniel's Nails. 4th edition, Springer, Philadelphia, 2018. He is also stakeholder of Medimetriks. Vinayak K. Nahar has received grants from Banfield Pet Hospital and Pfizer. Julia Wells and Kylie Watson have no conflicts of interest. |
